Table 5.
Classification and information on target components-related pathways, direct (top 20).
| Classification | Pathway | P value | Annotated genes count |
|---|---|---|---|
| Signaling molecules and interaction | Neuroactive ligand-receptor interaction | 4.25E − 24 | 15 |
| Signal transduction | GPCR downstream signaling | 1.17E − 15 | 15 |
| Signaling by GPCR | 6.64E − 14 | 15 | |
| Class A/1 (rhodopsin-like receptors) | 9.8E − 14 | 10 | |
| GPCR ligand-binding | 2.95E − 12 | 10 | |
| Peptide ligand-binding receptors | 1.98E − 10 | 7 | |
| G alpha (z) signaling events | 5.01E − 10 | 5 | |
| Dopamine receptors | 5.3E − 09 | 3 | |
| HIF-1 signaling pathway | 2.24E − 08 | 5 | |
| Organismal systems | Inflammatory mediator regulation of TRP channels | 1.38E − 14 | 8 |
| Dopaminergic synapse | 1.47E − 11 | 7 | |
| Human diseases | Amphetamine addiction | 3.01E − 09 | 5 |
| EGFR tyrosine kinase inhibitor resistance | 6.47E − 09 | 5 | |
| Morphine addiction | 1.32E − 08 | 5 | |
| Cellular processes | Gap junction | 1.12E − 08 | 5 |
| Transport of small molecules | Ion channel transport | 7.04E − 12 | 8 |
| Ligand-gated ion channel transport | 1.95E − 11 | 5 | |
| Transmembrane transport of small molecules | 1.44E − 10 | 10 | |
| Hemostasis | Platelet activation, signaling, and aggregation | 3.32E − 09 | 7 |
| Disinhibition of SNARE formation | 5.3E − 09 | 3 |